Advertisement
News
Advertisement

South Korea is a "key market" in Covidien's global strategy

Tue, 08/27/2013 - 1:36pm
Mass Device

Covidien launches a $21 million innovation center in South Korea, a country the medical device giant calls key to its international plans.

Covidien launches $21M R&D center in South Korea

Massachusetts medical device maker Covidien (NYSE:COV) is opening the doors on a new Center of Innovation in South Korea, a country that the company calls "a key market in our global strategy."

Covidien plans to spend $21 million over the course of 3 years to support the center, which will focus on engaging local healthcare professionals in design and development of medical devices in order to tailor solutions for the market.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading